Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.95
-0.06 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
9.96
+0.01 (0.10%)
After-hours: Apr 28, 2026, 4:11 PM EDT
Bioventus Employees
Bioventus had 930 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
930
Change
n/a
Growth
n/a
Revenue / Employee
$610,846
Profits / Employee
$24,443
Market Cap
830.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 930 | 0 | - |
| Sep 27, 2025 | 950 | -80 | -7.77% |
| Jun 28, 2025 | 950 | -80 | -7.77% |
| Mar 29, 2025 | 930 | -65 | -6.53% |
| Dec 31, 2024 | 930 | -40 | -4.12% |
| Sep 28, 2024 | 1,030 | 60 | 6.19% |
| Jun 29, 2024 | 1,030 | 80 | 8.42% |
| Mar 30, 2024 | 995 | -45 | -4.33% |
| Dec 31, 2023 | 970 | -150 | -13.39% |
| Sep 30, 2023 | 970 | -190 | -16.38% |
| Jul 1, 2023 | 950 | -210 | -18.10% |
| Apr 1, 2023 | 1,040 | -110 | -9.57% |
| Dec 31, 2022 | 1,120 | -80 | -6.67% |
| Oct 1, 2022 | 1,160 | 260 | 28.89% |
| Jul 2, 2022 | 1,160 | 260 | 28.89% |
| Apr 2, 2022 | 1,150 | 250 | 27.78% |
| Dec 31, 2021 | 1,200 | 500 | 71.43% |
| Oct 2, 2021 | 900 | 220 | 32.35% |
| Jul 3, 2021 | 900 | 220 | 32.35% |
| Apr 3, 2021 | 900 | 220 | 32.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 26, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 27, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| QuidelOrtho | 6,500 |
| Integra LifeSciences Holdings | 4,427 |
| CONMED | 3,900 |
| Avanos Medical | 2,287 |
| Cytek Biosciences | 702 |
| InMode | 660 |
| SS Innovations International | 483 |
| CeriBell | 327 |
BVS News
- 4 hours ago - Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026 - GlobeNewsWire
- 7 weeks ago - Bioventus Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026 - GlobeNewsWire
- 3 months ago - Bioventus Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 4 months ago - Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 5 months ago - Bioventus Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts